Statistics from Altmetric.com
Q What is the efficacy of various treatments for gastro-oesophageal reflux for prolonged non-specific cough in adults and children?
Medline (1966–2004), OldMedline (1951–65), EMBASE/Excerpta Medica (1997–2004), Cochrane Controlled Trials Register (searches current as of April 2005); reference lists of relevant studies; and communication with authors.
Study selection and assessment:
randomised controlled trials (RCTs) of adults and children receiving any gastro-oesophageal reflux disease (GORD) treatment (ie, anti-reflux conservative measures, H2 receptor antagonists, proton pump inhibitors [PPIs], or surgical therapy) for chronic non-specific cough lasting ⩾3 weeks (dry, non-productive cough without any other respiratory symptoms, signs, or systemic illness). 12 RCTs met the selection criteria; 3 trials involved infants and children (n = 198), and 9 trials involved adults (n = 196, mean age 48–58 y). 6 RCTs compared PPIs and placebo; 1 compared PPIs and ranitadine; 1 compared cisapride and a diet intervention; and 1 compared H2 antagonists and placebo. …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.